Corcept Therapeutics Inc. buy Truist Financial Co.
Start price
16.02.24
/
50%
€22.60
Target price
16.02.25
€39.06
Performance (%)
36.42%
Price
07.06.24
€30.83
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc. has seen massive gains of 36.42%. This prediction currently runs until 16.02.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corcept Therapeutics Inc. | 5.510% | 5.510% |
iShares Core DAX® | -0.258% | 0.299% |
iShares Nasdaq 100 | 2.964% | 4.660% |
iShares Nikkei 225® | 1.217% | -2.160% |
iShares S&P 500 | 1.732% | 2.807% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $36.00 to $42.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.31
04.06.24
04.06.24
€59.79
04.06.25
04.06.25
1.72%
07.06.24
07.06.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.88
02.05.24
02.05.24
€41.15
02.05.25
02.05.25
34.75%
07.06.24
07.06.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
06.11.23
06.11.23
€35.38
06.11.24
06.11.24
28.46%
07.06.24
07.06.24